Solid Tumor Research

Robust molecular profiling from tissue and liquid biopsies

Archer® Solid Tumor research panels offer a sensitive targeted sequencing approach for biomarker detection from both liquid and tissue biopsies. 

This approach leverages DNA, RNA or ctDNA input types for sensitive characterization of all variant types from low-input clinical research samples.

Key Features

Unified
Workflow

All Archer panels are powered by Anchored Multiplex PCR (AMP™) chemistry and follow the same simple workflow for maximum efficiency.

Comprehensive Tumor Profiling

Get the most information from your low-input FFPE sample - fusions, copy number variations (CNVs), single-nucleotide variant (SNVs), indels and expression levels

Confident Variant Detection

Purpose-built bioinformatics and molecular barcoding powers confidence variant detection.

Customization

Create from scratch or modify any existing panel to match the pace of discovery.

Partner Agnostic Fusion Detection

RNA-based assays detect both known and novel fusions

RNA Input
Input
Reads
Genes
RNA
500k
14
RNA
1.5M
26
ctDNA Input
Input
Reads
Genes
ctDNA
5M
28
DNA Input
Input
Reads
Genes

NTRK fusion detection in solid tumors

NTRK fusions are critical events in cancer biology, with known and unknown fusion partners that are notoriously difficult to detect. Archer FusionPlex® next-generation sequencing (NGS) panels provide sensitive NTRK fusion detection from RNA without prior knowledge of fusion partners.

RNA Input
Input
Reads
Genes
RNA
500k
14